Merck (NYSE:MRK) marked a major milestone in its bid to introduce a new formulation for its famous cancer therapy ...

On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...

Nov. 18, 2024 /PRNewswire-PRWeb/ -- Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a minimally-invasive, palliative procedure designed for patients whose cancer has metastasized and ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

The health district's needle exchange program is doing its job and reducing harm, officials told the Yakima City Council.